Form 8-K · Current Report · Filed 2026-01-29
Hologic Reports Q1 2026 Financial Results
Hologic, Inc. announced its financial results for the first quarter of fiscal 2026, reporting total revenue of $1,047.8 million, a 2.5% increase from the prior year. GAAP diluted EPS was $0.79, a 9.2% decrease due to favorable foreign exchange gains in the prior year. Non-GAAP diluted EPS increased by 1.0% to $1.04. The company also provided non-GAAP financial measures, including organic revenue, organic revenue excluding COVID-19, non-GAAP gross margin, non-GAAP operating margin, and adjusted EBITDA.
- Filer
- Hologic Inc. HOLX · NASDAQ
- Filed
- Accession
- 0001140361-26-002796
- CIK
- 0000859737
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$75.10
Next session
-0.2%
Since filing
+1.2%
Latest close
$76.01
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from HOLX reporting the same item, with the next session's move:
About Hologic Inc.
Hologic Inc. is a leading global medical technology company focused on improving women's health and well-being. Its primary function is to develop, manufacture, and supply diagnostic products, medical imaging systems, and surgical products, which play crucial roles in the prevention and treatment of diseases. Hologic's key sectors include breast health, diagnostics, gynecological surgical, and skeletal health solutions. It is renowned for innovative technologies such as 3D mammography or tomosynthesis, which are significant advancements in breast cancer detection. With a commitment to enhancing healthcare quality and efficiency, Hologic operates across a diverse range of healthcare settings, from hospitals and clinics to laboratories and research facilities. Headquartered in Marlborough, Massachusetts, Hologic has established itself as a pivotal player in women's health diagnostics, contributing to its substantial market presence and influence in the global healthcare sector.
Never miss another HOLX filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.